Dr. Kraft is a Stanford and Harvard trained physician-scientist with over 20 years of innovative biomedical research and clinical experience. He is an NIH funded faculty member with the Stanford Institute for Stem Cell Biology and Regenerative Medicine and is on clinical faculty with the UCSF pediatric bone marrow transplantation service.
Daniel has extensive research experience focused on stem cell biology and immunology. In early research experience at the National Institutes of Health, he was the first to propose and demonstrate proof of concept for a monoclonal antibody based therapy for allergic disease, an approach later translated to a novel humanized antibody therapeutic by Genentech (Xolair). As a Howard Hughes research fellow at Stanford he discovered a novel population of developing human T-cells, which play a role in HIV infection. His research focus after returning to Stanford has been on stem cell derived immunotherapy, working to understand and engineer the stem cell niche, and new antibody based conditioning regimens for stem cell transplantation. He has multiple peer-reviewed publications including in the journals Science and Nature, book chapters, and has lectured extensively on stem cell biology and regenerative medicine.
Daniel has additional research and clinical expertise in aerospace medicine (serves as flight surgeon with an F-16 squadron in the California Air National Guard) with whom he has deployed to Nicaragua and Saudi Arabia. He has published physiology research with NASA, with whom he was recently a finalist for astronaut selection.
Dr. Kraft is founder and consulting chief medical officer for StemCor Systems, a venture and corporate funded clinical stage medical device company based on his inventions, developing tools to enable adult stem cell based regenerative therapies, including the FDA approved ‘’MarrowMiner’’, a device which enables the rapid, less invasive harvest of bone marrow stem cells.
While a resident at Harvard, Daniel founded, developed, and operated one of the first internet based marketplaces for medical students and professionals, The Online Medical Bookstore, which was acquired by Netivation.com in conjunction with its IPO. Daniel helped found and serves as advisor to Wellsphere.com and also served as an advisor to multiple biotechnology companies. He is a venture partner and Kauffman Fellow with Proteus Venture Partners.
Dr. Kraft obtained a degree in Biochemistry cum laude from Brown University, and went on to complete medical school at Stanford University, where he was a Howard Hughes Research Fellow and graduated with honors in research. After medical school Dr. Kraft completed the four-year Harvard Combined Residency in Internal Medicine and Pediatrics at the Massachusetts General Hospital and Boston Children’s Hospital. Dr. Kraft then returned to Stanford for fellowship training in Hematology/Oncology and an additional fellowship in Bone Marrow and Hematopoietic Stem Cell Transplantation and a postdoctoral research fellowship in the stem cell laboratory of Irv Weissman. He is board certified in Internal Medicine, Pediatrics and BE in Hematology/Oncology.
Reach business leaders and technology influencers at the Web 2.0 Summit. Call Marco Pardi at (415) 947-6216 or email firstname.lastname@example.org.
View a complete list of Web 2.0 Summit contacts.